Effect of Melan-Α/Μart-1-peptide vaccination plus IMP321 on antitumor immunity and clinical benefit in patients receiving autologous PBMCs after lymphodepletion.
Emanuela Romano
Research Funding - Fond'Action
Helene Bichat
No relevant relationships to disclose
Athina Stravodimou
No relevant relationships to disclose
Pedro Romero
No relevant relationships to disclose
Speiser E Daniel
No relevant relationships to disclose
Frederic Triebel
Employment or Leadership Position - Immutep
Stock Ownership - Immutep
Olivier Michielin
No relevant relationships to disclose
Alexander Harari
No relevant relationships to disclose
Serge Leyvraz
No relevant relationships to disclose